MVP — Medical Developments International Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSuper Stock

Market Cap
AU$41.12m
Enterprise Value
AU$21.42m
Revenue
AU$42.57m

Annual income statement for Medical Developments International, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	C2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	21.9	32.3	33.1	39.1	42.6
Cost of Revenue
Gross Profit	15.2	22.2	24.4	29.4	30.7
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	38.2	59.3	66.4	40.8	41.5
Operating Profit	-16.3	-27	-33.2	-1.76	1.06
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-15.9	-7.49	-32.9	0.168	0.504
Provision for Income Taxes
Net Income After Taxes	-12.4	-5.61	-41	0.094	0.626
Net Income Before Extraordinary Items
Net Income	-12.4	-5.61	-41	0.094	0.626
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-12.4	-5.61	-41	0.094	0.626
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.159	-0.142	-0.343	0.001	0.005
Dividends per Share